German industry wants say in reimbursement decisions:
This article was originally published in Clinica
Germany's BVMed industry association says its knowledge and expertise should be used by the health ministry's reimbursement bodies when it comes to decision-making on healthcare products. In a recent position paper (see www.bvmed and go to Publikationen- Stellungnahme), the Berlin association said its practical, industry-relevant insight would be valuable to the joint federal committee (G-BA) and its executive arm, IQWiG in bringing cost-effective, innovative advanced medical technologies into circulation. BVMed director Joachim Schmitt has long campaigned for industry to be better consulted on technical medtech issues, on cost-benefit grounds and for the benefit of German patients (see Clinica No 1157, p 8).